• home
  • About Uzzi Reiss
  • Condition Treatment Protocol
  • Customer service

Chapter XX: What Every Natural Superwoman Needs to Know About Proactively Preventing & Confronting Breast-Cancer

326 Studies indicate women’s fears of breast cancer far exceed reality: Presentation South Atlantic Association OB/Gyn Boca Raton 2004 Levin.
327 Diet and environmental exposure during pregnancy increase risk of future breast cancer: Trends Endocrinol Metab. 2006 Nov;17(9): 340-8. Hilakivi-Clarke L et al.
327 Prenatal exposure to bisphenol (very common estrogen like chemical) induces breast cancer: Environ Health Perspect. 2007 Jan;115(1):80-6. Durando M et al.; Environ Health Perspect. 2007 Apr;115(4):592-8. Wadia PR et al.
327 Alcohol consumption during pregnancy and risk of future breast cancer in unborn daughter: Br J Cancer. 2004 Jun;1;90(11): 2225-31. Hilakivi-Clarke L et al.
327 High-fat diet and significant weight gain during pregnancy increase rates of breast cancer in offspring: Int J Cancer. 2006 Oct 1;119(7): 1537-46. De Assis S et al.
327 Use of DES increases occurrence of breast cancer in unborn daughters: Cancer epidemiol Biomarkers Prev. 2006 Aug;15(8): 1509-14. Palmer JR et al.
327 Study: adult women who have gained 55 pounds experience increased risk of breast cancer: JAMA. 2006 Jul 12;296(2):193-201. Eliassen AH et al.; Semin Oncol. 2006 Apr;33(2 Suppl 7):2-7. Forbes JF.
328 Birth control significantly increase incidence of breast cancer, risk is much higher if oral contraceptive start at young age: Breast Cancer Res Treat. 1998 Jul;50(2):175-84. Ursin G et al.; J Natl Cancer Inst. 1994 Apr 6;86(7):505-14. White E et al.; Contraception. 1996 Sep;54(3 Suppl):1S-106S.
328 Teenage pregnancy decreases breast cancer for life: Int J Food Sci Nutr. 1995 Nov;46(4):373-81. Walker AR et al.
328 Gain of more than 22 pounds since menopause increases risk of breast cancer: JAMA. 2006;296: 193-201. Eliassen AH et al.
328 Consumption of bad fat (Omega 6) increase risk of breast cancer: Cancer Causes Control. 2002 Dec;13(10): 883-93. Wirfalt E et al.
328 Red meat increases risk of breast cancer: Arch Intern Med. 2006 Nov 13;166(20): 2253-9. Cho E et al.
328 More than 1.5 servings of red meat a day increases risk of breast cancer bt 97%: Arch Intern Med. 2006 Nov 13;166(20): 2253-9. Cho E et al.
328 Increased risk of breast cancer by taking birth control between the ages of 15 and 20: Eur J Cancer. 2005;41(15): 2312-20. Jernstrom H et al.
329 Weight and girth gain during pregnancy increases breast cancer risk: J Nutr. 2006 Apr;136(4): 998-1004. De Assis S et al.
329 Waist hip ratio and weight gain over life time increases breast cancer risk: International J of Cancer. 2002;99: (3): 445-52. Friedenreich CM et al.
329 Weight gain of 38 pounds during pregnancy increase breast cancer risk: American Association for Cancer Research meeting 4/9/02 investigator for George Town University.
329 Antibiotic treatment significantly increases risk for breast cancer: JAMA. 2004;291(7): 827-35. Christine M et al.
329 Increased breast cancer risk due to proliferation of abnormal bacteria due to antibiotic treatment: Cancer Res. 2007 Feb 1;67(3): 847-50. Rao VP et al.
329 Certain groups more susceptible to environmental pollutants: Contraception. 1996 Sep;54(3 Suppl):1S-106S.
330 Study: significant stress doubles breast cancer risk: LA Time. Sep 24, 2002 Health section cancer Conference Copenhagen et al. Med Hypotheses. 2007;68(5):1138-43. Gago-Dominguez M et al.; Mol Cell Biochem. 2007 Aug 11; Zweitzig Dr. et al.
330 Job strain increase risk of breast cancer: Epidemiology. 2007 Sug 30; Kuper H et al.
330 Stress history increase recurrence of breast cancer: J Psychosom Res. 2007 Sep;63(3):233-9 Palesh O et al.
330 Stress increases metastasis marker in breast cancer cell: Mol Cell Biochem. 2007 Aug 11; Zweitzig DR et al.
330 Studies demonstrating iodine deficiency increase risk for breast cancer: Trans New York Acad Sciences. 1970;32: 911-47. Eskin BA.; Breast. 2001 Oct;10(5):379-82. Venturis S.; Cancer Causes Control. 2000 Feb;11(2):121-7. Cann SA et al.; Adv Exp Med Biol. 1977;91:293-304. Eskin BA.
330 SSRIs like Prozac, Zolof etc. increase uncommon but aggressive type of breast cancer: Breast Cancer Res Treat. 2005 Dec 2;: 1-10. Chien C et al.
330 It takes 15 years until 2 breast cancer cells reach size of 1 cm: Jpn J Cancer Res. 1990 May;81(5):454-62. Kuroishi t et al.
331 Breast cancer risk drops with each pregnancy by 7%: LANCET. 2002;360(9328): 187-95.
331 Women with breast cancer who get pregnant live longer and have less recurrences comparing to women with breast cancer that do not get pregnant: BMJ. 2007 Jan 27;334(7586):194. Ives A et al.; Ob. Gyn News. 2006 Jul 13: P2. Largillier R.; J Steroid Biochem Mol Biol. 2007 Jul 20; Monteiro R et al.; Cancer. 2003 Sep 15;98(6):1131-40. Mueller BA et al.; Laeknabladid. 2000 July/august;86(7/8):495-498. Birgisson H et al.; Cancer. 1999 Jun 1;85(11):2424-32. Valentgas P et al.
331 Aromatization is the process that converts testosterone to estrogen in the breast: J Br Med J 1998;296(6624)741-3. O’Neill JS et al.
331 Inflammation with increase of TNFk, NFKbeta, IL6/IL12 and COX-2 activity promote aromatization and increase aggressiveness metastasis ability and resistance to treatment of breast cancer: Endocr Relat Cancer. 2005 Jul;12 Suppl 1: S37-46. Zhou Y et al.; Egypt J Immunol. 2004;11(2): 165-70. Hussein MZ et al.; Endocr Relat Cancer. 2006 Jun;13(2): 607-616. Montagut C et al.; Endocrinology. 2005 Nov;146(11): 4917-25. Saitoh M et al.
331 Women who have 7 or more mammograms increase breast cancer risk by 80%: Breast Cancer Res Treat. 2007 Jul 7; Ma H et al.
331 X-ray before age 20 increase breast cancer by 40% in women with cystic breast: Cancer Causes Control. 2002 Oct;13(8):711-8. Hill DA et al.
331 Women that have radiation as treatment for breast cancer have significant increase in heart attack incidence: Radiother Oncol. 2007 Mar;82(3):294-300. Paszat LF et al.
331 Grapefruit intake may increase risk of breast cancer: Br J Cancer. 2007 Jul 10; Monroe KR et al.
331 Women who where exposed to higher dose of DDT at young age has significant risk of increase breast cancer: Los Angeles Times, By Maria Cone. September 30 2007: Chief investigator Cohn BA.
331 Indole-3-carbinol abolish negative affect of DDT on the breast: Acta Biochim Pol. 2007;54(1):113-7. Ociepa-Zawal M et al.
331 Exposure to higher dose of DDT increases breast cancer: J Natl Cancer Inst. 1993 Apr 21;85(8):648-52. Wolff MS et al.
331 Excessive iron increases the risk of breast cancer: Cancer Causes Control. 2007 Dec;18(10):1047-53. Kabat GC et al.;
331 Genetic risk for increase iron level associated with increase post menopausal breast cancer: Cancer Epidemiol Biomarkers Prev. 2007 Sep;16(9):1784-94. Hong CC et al.
331 HPV virus Epstein-Bar virus and mouse mammary tumor virus may have a role in the development of cancer: Future Microbiol. 2006 Jun;1:33-51. Lawson JS et al.
331 Oxidative stress contribute to the development of breast cancer: Clin Biochem. 2007 Oct;40(15):1129-34. Delimaris I et al.
331 Progesterone and 17 Beta HSD 2 metabolize estradiol to estrone: Breast Cancer. 2006:13(2): 129-36. Sasano H et al.
332 Evening primrose oil (gamma linolenic acid) enhances positive treatment result of women with Her-2/neu expression in breast cancer: J Natl Cancer Inst. 2005 Nov 2:97(21):1611-5. Menendez JA et al.
332 Evening primrose oil (GLA) may be protecting breast cancer metastasis: J Cell Biochem. 2007 May 1;101(10):155-66. Martin TA et al.
332 Flax seed slow breast cancer metastasis by decrease VEGFs: Cancer Lett. 2002 Nov 8;185(1):31-7. Dabrosin C et al.
332 Flax seed inhibit breast cancer and improve tamoxifen treatment: Clin Cancer Res. 2004 Nov 15;10(22):7703-11. Chen J et al.
332 Fish oil protects us from breast cancer: Int J Cancer. 2005 Nov 10;117(3): 340-8. Wu M et al.; Breast Cancer Res Treat. 1995 Jun;34(3): 199-212. Chajes V et al.; Oncol Rep. 2007 Apr;17(4):713-9. Jourdan ML et al.
332 Fish oil and vitamin E decrease breast cancer cell growth: Breast Cancer Res Treat. 1995 Jun;34(3):199-212. Chajes V et al.
332 Perimenopausal women cosuming more Omega-3 and less Omega-6 less likely to develop breast cancer: J Nutr. 2003 May;133(5): 1409-14. Goodstine SL et al.
332 CLA inhibits cell proliferation in cancer cells: Exp Mol Pathol. 2005 Oct;79(2): 118-25. Albright CD et al.
332 Whey and whey acid proteins inhibits proliferation and spread of breast cancer: J Cell Physiol. 2007 May31; Nukumi N et al.; Cancer Lett. 2007 Jul 8;252(1):65-74. Nukumi et al.
333 Soy and soy products decrease breast cancer and decrease breast cancer resistance to treatment: Oncogene. 2005 Apr 7;24(15):2558-67. Kim SO et al.; J Natl Cancer Inst. 2007 Mar 21;99(6):475-86. Touillaud MS et al.; Cancer Res. 2004 Jun 15;64(12):4346-52. Imai Y et al.
333 Consuming ginger may dcrease breast cancer resistance: Oncogene. 2005 Apr 7;24(15): 2558-67. Kim So et al.
333 Curcumin’s anti-inflammatory and anti-tumor affect as significant protection from breast cancer: Mutat Res. 2001 Sep 1;480-481: 243-68. Surh YJ et al.; Anticancer Res. 2005 Sep-Oct;25(5): 3293-302. Ramachandran C et al.; Int J Mol Med. 2007 Sep;20(3):329-35. Poma P et al.; Cancer Res. 2007 Apr 15;67(8):3853-61. Kunnumakkara AB et al.
333 Investigation of green tea as treatment for breast cancer: IDrugs. 2003 Nov: 6(11): 1073-8. Rosengren RJ.
333 Green tea as an anti-inflammatory and COX-2 inhibitor: Mutat Res. 2001 Sep 1;480-481: 243-68. Surh YJ et al.; Int J Cancer. 2005 Feb 10;113(4): 660-9. Hussain T et al.
333 Green tea decreases aggressive nature of cancer cells: Nutr Cancer. 2005;52(1): 66-73. Slivova V et al.
333 Green tea inhibiting destructive effect of Her-2/neu and (EGFR) that are significant risk factor in breast cancer: Clin Cancer Res. 2003 Aug 15;9(9): 3486-91. Masuda M et al.
333 Green tea enhances efficiency of Taxol: Clin Cancer Res. 2003 Aug 15;9(9): 3486-91. Masuda M et al.
333 Taxol standard breast cancer toxic chemotherapy found not to be effective but with patients with HER2:
333 Grape juice, grape seeds, and red wine as aromatase inhibitors for prevention of breast cancer: Ann N Y Acad Sci. 2002;963: 229-38. Chen S.; Cancer Res. 2006 Jun 1;66(11): 5960-7. Kijima I et al.; Breast Cancer Res Treat. 2001 May;67(2): 133-46. Eng ET et al.; Ann N Y Acad Sci. 2002 Jun;963: 239-46. Eng ET et al.
334 Resveratrol is a COX-2 inhibitor: Biofactors. 2004;21(1-4): 33-9. Kundu JK et al.
334 Resveratrol is a NFkB inhibitor: Int J Mol Med. 2006 Jun;17(6): 1069-75. Kim YA et al.
334 Resveratrol regresses tumor formation: Arch Int Med. 1991;151: 75. Henderson BE et al.
334 Resveratrol as a reason for the so-called “French Paradox”: Mol Nutr Food Res. 2005 May;49(5): 452-61. Ulrich S et al.
334 Pomegranates decrease NFkB: Int J Cancer. 2005 Jan 20;113(3): 423-33. Afaq F et al.; Breast Cancer Res Treat. 2002 Feb;71(3): 203-17. Kim ND et al.
334 Pomegranates decrease breast cancer cell proliferation: J Med Food. 2005 Winter;8(4): 469-75. Jeune MA et al.
334 Pomegranate prevents breast cancer cells from developing new blood vessels and progression: Angiogenesis. 2003;6(2): 121-8. Toi M et al.; Eur J Cancer Prev. 2004 Aug;13(4): 345-8. Mehta R et al.
335 Mushrooms that serve as a treatment option for estrogen receptor negative breast cancer: Oncol Rep. 2006 Feb;15(2): 417-23. Gu YH et al.
335 Ganoderma lucidum mushrooms down regulate NFkB inhibit breast cancer: Int J Oncol. 2006 Sep;29(3): 695-703. Jiang J et al.
335 White button mushroom is chemo preventive in breast cancer via anti aromatase activity: J Nutr. 2006 Apr;136(4):998-1004. de Assis S et al.
335 Perimenopausal women consuming more than 30 grams of fiber daily decrease breast cancer: Int J Epidemiol 2007 Apr;36(2):431-8. Cade J et al.
335 2 Metoxyestradiol protect against breast cancer: Circ Res. 2006 Aug 4;99(3): 266-74. Barchiesi F et al.
335 16 Hydroxy esterone increase breast cancer risk: Maturitas. 2006 Apr 20;54(1): 72-7. Seeger H et al.
335 Breast cancer patients have higher levels of 16 Hydroxy esterone: Cancer Epidemiol Biomarkers Prev. 1997;6: 505-9. Kabat GC et al.
335 Breast cancer patients have lower levels of 2 Hydroxy esterone: Epidemiology. 2000 Nov;11(6):635-40. Muti P et al.; Epidemiology. 2006 Jan;17(1):80-8. Kabat GC et al.; Steroids. 2003 Jan;68(1):65-72. Fowke JH et al.
335 DIM supplements increase 2 Hydroxy esterone and may protect from breast cancer: Nutr Cancer. 2004;50(2): 161-7. Dalessandri KM et al.
335 Indol3 Carbinol supplements increase 2 Hydroxy esterone: J Cell Biochem Suppl. 1997;28-29: 111-6. Wong GY et al.; Apoptosis. 2006 May;11(5): 799-812. Moiseeva EP et al.; Oncogene. 2001 May 24;20(23): 2927-36. Chinni SR et al.
335 Indol3 Carbinol reduces epidermal growth factor receptors that usually increase cancer progresion: Apoptosis. 2006 May;11(5): 799-812. Moiseeva EP et al.; Carcinogenesis. 2007 Feb;28(2): 435-45. Moiseeva EP et al.
335 High level of 2 Hydroxyesteron associated with osteoporosis: J Clin Endo Meta. 2005;90(4):2035-2041. Napoli N et al.; J Bone Miner Res. 2000 Dec;15(12):2513-20. Leelawattana R et al.
335 Breast cancer associated with increase bone density: Maturitas. 2006 Oct 16; Hadju P et al.
335 Snips in 1B1 increase 4 OH estrone that increase breast cancer: Cancer Epidemiol Biomarkers Prev. 2001 Mar;10(3): 209-216. Goodman MT et al.; Cancer Res. 2000 Jul;60(13):3440-3444. Hanna IH et al.; Endocr Rev. 2000 Feb;21(1):40-54. Liehr JG.; Afr J Reprod Health. 2006 Apr;10(1):13-25. Okobia MN et al.
335 Women with SNP in 1B1 have a 220% increase in risk of breast cancer: Cancer Epidemiol Biomarkers Prev. 2000;9(2):147-150. Zheng W et al.
335 DHEA suppresses production of 4 Hydroxy esterone: Mol Cell Biochem. 1999 Aug;198(1-2) 89-100. Ikegwuonu FI et al.
335 COMT defect increases breast cancer: Cancer Res. 1998;58: 2107-2110. Thompson PA et al.; Cancer Res. 1999;59: 4870-4875. Huang CS et al.; Cancer Res. 1997 Dec 15;57(24):5493-7. Lavigne JA et al.
335 Overweight women with COMT defect have higher risk of breast cancer: Cancer Res. 1998 May 15;58(10):2107-10. Thompson PA et al.; Cancer Res. 1999 Oct 1;59(19):4870-5. Huang CS et al.
335 COMT defect and Folic Acid deficiency are risk for breast cancer: Carcinogenesis. 2001;22(10): 1661-1665. Goodman JE et al.
335 GST protects from pollutants and toxins: Cancer Epidemiol Biomarkers Prev. 2001;10: 229-236. Mitrunen K et al.
335 GST SNP defect increase breast cancer risk by 50%: Cancer Epidemiol Biomarkers Prev. 2001;10: 229-236. Mitrunen K et al.; J Natl Cancer Inst. 1998;90: 512-518. Helzlsouer KJ et al.
335 Combination of SNPs in COMP and GST further increase breast cancer risk: Pharmacogenetics. 2002;12: 67-72. Mitrunen K et al.
335 Uderstanding personal risk of developing breast cancer: Fertil Steril. 2004 Jul;82(1):132-7. Clemens B et al.
335 Hope is aromatase inhibitor and may decrease breast cancer: J Steroid Biochem Mol Biol. 2007 Jul 20; Monteiro R et al.;
336 Sulforaphane (SGS) stop breast cancer growth: Drug Discov Today. 2004 Nov 1;9(21):908. Johnston N.; Endocrinology. 2006 Sep;147(9):4132-50. Zhu BT et al.; Mol Cancer Ther. 2007 Mar;6(3):1013-21. Pledgie-Tracy A et al.; Mol Cells. 2005 Dec 31;20(3):364-70. Kim SJ et al.; Life Sci. 2006 May 22;78(26):3043-50. Thejass P et al.; Vascul Pharmacol. 2007 Feb;46(2):77-84. Jackson SJ et al.;
335 Royal jelly inhibits growth in breast cancer cells: Biosci Biotechnol Biochem. 2007 Jan;71(1): 253-5. Nakaya M et al.
336 Quercetin increases protection from breast cancer: Cancer Biol Ther. 2007 Jan 29;6(1). Dechsupa S et al.
336 Selenium down-regulated estrogen Receptor Alpha expression: Breast Cancer Res Treat. 2005 Aug;92(3): 239-50. Shah YM et al.; J Cell Biochem. 2007 Jan 22; Martin TA et al.
336 Vitamin E Tocotrienol functions as an anti-cancer mechanism in pre-cancer and cancer cells: Exp Biol Med. 2005 Apr;230(4): 235-41. Shah SJ et al.; Asia Pac J Clin Nutr. 2005;14(4): 366-73. Sylvester PW et al.; Ann N Y Acad Sci. 2004 Dec;1031: 143-57. Nesaretnam K et al.; Biochem Biophys Res Commun. 2006 Jul 28;346(2): 447-53. Srivastava JK et al.; Cancer Detect Prev. 2005;29(4): 383-8. Yu FL et al.
337 Vitamin D decreases growth of breast cancer cells: J Steroid Biochem Mol Biol. 2005 Oct;97(1-2): 103-9. Townsend K et al.; J Steroid Biochem Mol Biol. 2003 Feb;84(2-3): 149-57. Wietzke JA et al.; Oncogene. 2000 Oct 19;19(44): 5091-7. Campbell MJ et al.; Acta Pharmacol Sin. 2007 Sep;28(9):1373-82. Welsh J.
337 Co-Enzyme Q10 produces complete and partial remission of breast cancer: Biochem Biophys Res Commun. 1994 Mar 30;199(3): 1504-8. Lockwood K et al.
337 Lycopene is a suppressor of the initiation process of breast cancer: Pharmacogenomics. 2006 Jul;7(5): 663-72. Chalabi N et al.; Toxicol In Vitro. 2007 Mar;21(2):217-23. Fornelli et al.
337 Vitamins B-12 and B-6 decrease incidence of breast cancer: J Natl Cancer Inst. 2003 Mar 5;95(5): 373-80. Zhang SM et al.
338 Physical activity decreases the risk of invasive breast cancer: Cancer Epidmed Biomarkers Prev. 2007 Feb;16(12): 236-43. Sprague BL et al.
338 Physical activity decrease estrogen-Positive progesterone-Negative breast cancer: Arch Intern Med. 2006 Dec 11-25;166(22): 2478-83. Bardia A et al.
338 1991 Harvard University study about wearing bras and increase incidence of breast cancer: Eur J Cancer. 1991 27: 131-5. Hsieh CC et al.
339 Bra use decreases Melatonin: Chronobiol Int. 2000 Nov;176: 783-93. Lee YA et al.
339 Large bra cup sizes in young women increase risk of perimenopausal breast cancer: Int J Cancer. 2006 Apr 15;118(8): 2031-4. Kusano AS et al.
339 Bra use for 18-24 hours per day increase breast cancer risk more than 100 fold: Dressed To Kill 1995. Avery Press Singer S et al.
339 Stoping to use bra stop shoulder pain: Clin Endocrinol 2006;64(1)20-8. Enriori PJ et al.
340 Study indicating that bra wear results in future breast sagging: J Hum. Ergol. 1990 Jun; 19(1): 53-62. Ashizawa K et al.
340 Higher incidence of breast cancer in upper, outer quadrant of breast: J Appl Toxicol. 2003 Mar-Apr;23(2): 89-95. Darbre PD.
340 Nearly everything applied to upper, outer quadrant is toxic: Appl Toxicol. 2003 Sep-Oct;23(5): 285-8. Harvey PW.
340 Parabens has been identified in breast cancer tissue: J Appl Toxicol. 2005 Jul-Aug;25(4): 301-9. Pugazhendhi D et al.; J Appl Toxicol. 2004 May-Jun;24(3):167-76. Harvey PW et al.
340 Aluminum in antiperspirants associated with DNA alteration: J Inorg Biochem. 2005 Sep;99(9): 1912-9. Darbre PD.
340 Studies indicating longer use of anything on underarm, the earlier breast cancer diagnosis: Eur J Cancer Prev. 2003 Dec;12(6): 479-85. McGrath KG.
341 Full-term pregnancy and breast feeding decrease incidence of breast cancer: LANCET. 2002;360(9328): 187-95.
341 Pregnancy after breast cancer increase survival and decrease cancer recurrence comparing to breast cancer survivor that did not get pregnant: BMJ. 2007 Jan 27;334(7586):194. Ives A et al.; Cancer. 2003 Sep 15;98(6):1131-40. Mueller BA et al.; Laeknabladid. 2000 July/August;86(7/8):495-498. Birgisson H et al.; Cancer. 1999 Jun1;85(11):2424-32. Velentgas P et al.; Los Angeles Times. 2007 Sept 30;UC Berkley study main investigator. Barbara A Cohn.
341 Teenage pregnancy associated with decreased risk of breast cancer: Int J Food Sci Nutr. 1995 Nov;46(4): 373-81. Walker AR et al.
341 Mice given high doses of estrogen and progesterone at puberty reduced breast cancer by 60%, and eliminated HER-2/neu (HER-2): Breast Cancer Res. 2007 Jan 26;9(1): R12. Rajkumar L et al.
341 Breastfeeding decreases incidence of cancer by 4.3%: LANCET. 2002;360(9328): 187-95.
341 Nipple stimulation releases duct obstruction and free-radicals and may decrease breast cancer: Med Hypotheses. 1991 Dec;36(4): 389-96. Murrell TG.; Breast Cancer Res Treat. 1995 Aug;35(2): 225-9. Murrell TG.
342 Progesterone increases the production of oxitocyn: Breast Cancer Res Treat. 1995 Aug;35L2):225-9. Murrell TG.
342 Dhea and androgen protect from breast cancer: Endocrine Related Cancer. 2006;13:335-355. Labrie F.
342 Dhea and androgens inhibits breast cancer: Endo Review. 2003;24(2)”152-182. Labroe F et al.
342 Dhea decrease breast cancer proliferation: Cancer J. 2006 Mar-Apr;12(2):160-5. Gayosso V et al.
342 Dhea stop progression of breast cancer: Breast Cancer Res. 2005;7(6):R1132-40. Shilkaitis A et al.
342 Dhea and androgens are chemopreventive and novel cancer anti-proliferative by multiple mechanism: Curr Pharm Des. 2006;12(26):3411-21. Matsuzaki Y et al.
342 Dhea protect from breast cancer: Endo Relat Cancer. 2006 Jun;13(2):335-355. Labrie F.
342 Dhea is chemoprotive against breast cancer: Int J Cancer. 2003 Jun 20;105(3):321-5. Ciolino H et al.
342 Dhea is a treatment option to treating estrogen negative breast cancer: World J Surg. 2007 May;31(5);1041-6. Hardin C et al.
342 Androgen and dhea has inhibitory effect on breast cancer: Cancer Res. 2006 Aug 1;66(15):7775-82. Macedo LF et al.
342 DHEA suppresses and prevents growth of 4 Hydroxy esterone: C Y Mol Cell Biochem. 1999;198(1-2): 89-100. Ikeawuonu FL et al.
342 DHT inhibits growth of breast cancer: Breast Cancer Res. 2005;7(6): R1132-40. Shilkaitis A et al.
342 IGBP-3 inhibits growth of breast cancer: Cancer Res. 2004 Mar 15;64(6):2229-37. Kim HS et al.
342 Melatonin decrease breast cancer growth: J Pineal Res. 2006 May;40(4): 291-6. Martinez-Campa C et al.
342 Melatonin improve survival rates in animals with untreated breast cancer: Mol Cell Biochem. 2005 Oct;278(1-2): 15-20. Saez MC et al.
342 Melatonin causes the regression of breast cancer by behaving as an aromatase inhibitor: Breast Cancer Res Treat. 2005 Dec;94(3): 249-54. Martinez-Campa C et al.
344 Higher estriol levels in pregnancy translate to 58% reduction in future breast cancer: Prospective study of Estrogen during pregnancy risk of Breast Cancer; unpublished studies performed at the Public Health Institute in Oakland and funded by USA Army Medical Research. DAMD 17-99-1-9358 et al.
344 Estriol (E3) protect the development of ovarian cancer: J Endocrinol. 2007 Jun;193(3):421-33. Treeck O et al.
344 Adiponectin protects from breast cancer: J Clin Endocrinol Metab. 2007 Apr;92(4):1510-16. Tworoger SS et al.
345 Use of bioidentical estradiol and progesterone promotes decrease in breast cancer: Int J Cancer. 2005 Apr 10;114(3): 448-54. Fournier A et al.; Gynecol Endocrinol. 2006 Aug;22(8):423-31. Espie M et al.
345 Women with breast cancer given estrogen enjoyed higher survival rates: J Clin Oncol. 1999 May;17(5): 1482-7. Vassilopoulou-Sellin R et al.; Menopause. 2003 Jul-Aug;10(4):277-85. Decker DA et al.
345 Breast cancer surgery during highest level of estradiol enjoys better outcomes: Eur J Surg Oncol. 2001 Mar;27(2): 152-6. Holmberg L et al.
345 Estrogen increases apatosis: J Steroid Biochem Mol Biol. 2000;72(3-4): 89-102. Szelei J et al.
345 Estradiol decreases Interleukin-6: Egypt J Immunol. 2004;11(2): 165-70. Hussein MZ et al.; J Huazhong Univ Sci Technolog Med Sci. 2006;26(1):53-8. Wang Y et al.
345 Estradiol reduces NFkB: Endocr Relat Cancer. 2006 Jun;13(2): 607-616. Montagut C et al.; J Huazhung Univ Sci Technology Med Sci. 2006;26(1): 53-8. Wang Y et al.; Poster Endocrin Society. 2004 Page 334 P2 119. Liu H et al.; Mol Endocrinol. 2007 Oct 11; Nettles KW et al.
345 Estrogen receptor positive breast cancer is less aggressive: J Clinc Oncol. 1998 Sep;16(9): 3115-20. Holi IC et al.
345 Estrogen receptor positive has higher survivol rate: Neoplasma. 1993;40(1): 55-7. Heise E et al.; Int J Cancer. 1994 Nov;59(3): 351-6. Nagai MA et al.
345 Estradiol binds to Estrogen Receptor Beta that decrease breast cancer growth: Endocrinology. 2006 Sep;147(9):4132-50. Zhu BT et al.
345 Estrogens were common treatment against breast cancer: JAMA. 1997;237: 2079-85. Carter AC et al.; Endocrine Therapy In Malignant Disease. 1972;156-158. Stoll BA et al.
346 When conventional treatment fails for breast cancer with anti estrogen drug, adding estrogen can make it work again: Breast. 2005 Sep 29. Jordan VC et al.; World J Surg Oncol. 2006 Jul 11;4: 44. Agrawal A et al.; JAMA. 1997;237: 2079-85. Carter AC et al.; Med Pediats Oncol. 1990;18: 317-20. Boyer MJ et al.
346 Animals supplemented with estradiol, experienced a profound reduction in breast cancer tumor size: J The National Cancer Institute. 2002 Aug;94(15):1173. Jordan VK et al.; Clin Cancer Res. 2001;7:3156-65. Josleen VC et al.
346 Study showing estradiol treatment decreased breast cancer and the ability of it to multiply: Breast Cancer Research 2007 Jan 26. Lakshmanaswamy R et al.
346 Dr. Bush’s summarized 25 years and 50 reports on HRT and ERT and concluded that estrogen treatment is no risk factor for increase breast cancer: Obstet & Gynecol. 2001 Sep;98(3): 498-08. Bush TL et al.
346 Dr. Speroff professor OB/GYN of Oregon University said “HRT treatment is beneficial and make breast cancer cells more differential “: Menopause. 2007 Oct 8; Speroff L.
347 Studies confirm reduction of cancer death with use of HRT: Am J Obstet Gyn. 2002;186: 325-34. Nanda K et al.; Ann Endocrinol (Paris). 2007 Sep;68(4):241-250. Caufriez A.
347 WHI study’s use of Premarin only show 23% decrease breast cancer: JAMA. 2002 Jul 17;288(3): 321-33. Rossouw JE et al.
347 Harvard University study of use of Premarin alone shows no increase of incidence of breast cancer for 15 years: Cancer epidemiol Biomarkers Prev. 2006 Aug;15(8): 1509-14. Palmer JR et al.
347 Harvard University study shows Premarin-only use saw increase of breast cancer only after 20 years in breast cancer: LANCET. 1997;350(9084): 1047-59.
348 Risk associated with estrogen-only treatment is equal to risk from eating red meat five times a week: Arch Intern Med. 2006 Nov 13;166(20): 2253-9. Cho E et al.
348 Risk of breast cancer associated with estrogen-only is equal to taking 50+ days of antibiotics—45%: JAMA. 2004;291(7): 827-35. Christine M et al.
348 Risk associated with estrogen-only is lower than risk from gaining more than 38 pounds while pregnant: American Association for Cancer Research meeting 4/9/02 investigator for George Town University.
348 With family history of breast cancer, use of HRT decrease of death from breast cancer: Ann Inter Med. 1997;127(11): 75-78. Sellers TA et al.
348 Use of HRT prior to cancer diagnosis leads to be better survival rates and decrease of metastasis: Br J Cancer. 1999 Jul;80(9): 1453-8. Jernstrom H et al.
348 Use of HRT with breast cancer survivor decrease by 50% cancer recurrence comparing to breast cancer survivors that did not take HRT: Women’s Health. 2001 Oct. Desala PJ.; J Reprod Med 2004 Jul;49(7):510-26. Levgur M.
348 Study showing women with breast cancer treated with estrogen had higher survival rates: J Clin Oncol. 1999 May;17(5): 1482-7. Vassilopoulou-Sellin R et al.
348 Additional studies showing increased survival rates with use of estrogen in breast cancer survivors: J Natl cancer Inst. 2005 Apr 6;97(7):533-5. Von Schoultz E et al.; Obstet & Gynecol. 2001 Sep;98(3): 498-08. Bush TL et al.; Am J Obstet Gyn. 2002;186: 325-34. Nanda K et al.
349 study finding estrogen use in breast cancer survivors did not increase the breast cancer recurrence: J Natl Cancer Inst 2005;97(7)533-5. Von Schoultz E et al.
349 Use of HRT to early breast cancer survivor with follow up of more than 30 years show no increase in incidence and recurrence of breast cancer: Am J Obstet Gynecol. 2002 Aug;187(2):289-94. Natrajan PK et al.; Obstet Gynecol. 2007 Jun;109(6):1455. Harkins T.
349 Studies confirming increased survival decrease recurrence of cancer with estrogen use in breast cancer survival: Amer J OBGyn. 2002 Aug;187(2): 289-94. Puthugramam K et al.; Menopause. 2003 Jul-Aug;10(4): 277-85. Decker D et al.
349 Women with breast cancer treated with estrogen has higher survival and decrease recurrence comparing to group of breast cancer survivors not taking estrogen: Menopause. 2003 Jul-Aug;10(4): 277-85. Decker D et al.
349 Study showing bioidentical estradiol and progesterone caused a 10% reduction in breast cancer incidence compared to nonusers: Int J Cancer. 2005 Apr 10;114(3): 448-54. Fournier A et al.
349 French study of bioidentical estradiol and progesterone showed decrease breast cancer in user comparing to non user: Gynecol Endocrinol. 2006 Aug;22(8): 423-31. Espie M et al.
349 Mice with breast similar to women breast treated with bioidentical hormones showed significant reduction in breast cancer formation and progession: Breast Cancer Res. 2007;9(2):102. Rajku MAR et al.
349 The fact that use of bioidentical hormones may prevent breast cancer got notice and positive suggestions: Breast cancer Res. 2007;9(2):102. Jerry DJ
349 Estrogen preventive effect on the breast may be blocked by metabolite of cholesterol 27-Hydroxycholesterol: Mol Endocrinol. 2007 Sep 13; Dusell CD et al..
349 WHI study warnings: Ob.Gyn. News. 2007 Jan 1;42(1): 1. Jancin B et al.
349 Dr. Leon Speroff’s speaking publicly about problems with WHI study, “…diagnostic and selection biases…”: Ob Gyn News October 1, 2006. Dixon BK.
349 The world is embracing the use of estrogen and progesterone and emphasizing the safety of natural hormones comparing to the chemicalize hormones: Ann Endocrinol (Paris). 2007 Sep;68(4):241-250. Caufriez A.; Bull Cancer. 2007 May 1;94(5):469-75. Czernichow C et al.; Med J Aust. 2007 Jun 18;186(12):643-6. MacLennan AH.

« Back to chapter listing

The Beverly Hills Anti-Aging Center for Men and Women &
Advanced Nutrition and hormone-based gynecology

Beverly Hills Anti-Aging Center . About Dr. Uzzi Reiss .
Conditions . Customer Service . Genomic Breast Cancer . Super Woman Reference . Anti-Aging
Office Policies . Contact Us .
© 2013. All rights reserved.
Dr. Reiss' Books:
"The program described in The Natural Superwoman allows women who cannot come to see Dr. Reiss personally benefit from the same healthful resources and wisdom as those of us who do."
—Katey Segal, Actress (Married With Children/Eight Simple Rules for Dating My Daughter)

The Natural Superwoman Natural Hormone Balance for Women

How to Make a New Mother Happy How to Make a Pregnant Woman Happy